🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Apellis Pharmaceuticals, Inc.
Market Cap: High
Employees: Medium
pegcetacoplan
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic compounds targeting the complement system for autoimmune and inflammatory diseases.
Website
About | Leadership | Directors | About | About | Contact | Contact | Contact | Culture | Benefits | Careers | Careers | About | About
Symbol: APLS
Recent Price: $31.90
Industry: Biotechnology
CEO: Dr. Cedric Francois M.D., Ph.D.
Sector: Healthcare
Employees: 702
Address: 100 Fifth Avenue, Waltham, MA 02451
Phone: 617 977 5700
Leadership
- Cedric Francois, MD, PhD, Co-Founder & Chief Executive Officer/President
- Caroline Baumal, MD, Chief Medical Officer
- Mark DeLong, Chief Business & Strategy Officer
- Pascal Deschatelets, PhD, Co-Founder & Chief Scientific Officer
- Jeffrey Eisele, PhD, Chief Development Officer
- Karen Lewis, Chief People Officer
- Nur Nicholson, Chief Technical Operations Officer
- Timothy Sullivan, Chief Financial Officer
- Adam Townsend, Chief Operating Officer
- David Watson, JD, General Counsel
- Apellis Pharmaceuticals,
- Gerald Chan, Chairman
- Sinclair Dunlop, Director
- Stephanie Monaghan O’Brien, Director
- Paul Fonteyne, Director
- Cedric Francois, Co-Founder & Chief Executive Officer/President
- Alec Machiels, Co-Founder
Last updated: 2024-12-31